SEARCH

SEARCH BY CITATION

References

  • 1
    DeRisi J, Penland L, Brown PO et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996 Dec; 14 (4): 45760.
  • 2
    Ramsay G. DNA chips: state-of-the art. Nat Biotechnol 1998 Jan; 16 (1): 404.
  • 3
    Zhao X, Li C, Paez JG et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 2004 May 1; 64 (9): 306071.
  • 4
    Engle LJ, Simpson CL, Landers JE. Using high-throughput SNP technologies to study cancer. Oncogene 2006 Mar 13; 25 (11): 1594601.
  • 5
    McLendon R, Friedman A, Bigner D et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008 Oct 23; 455 (7216): 10618.
  • 6
    Ley TJ, Mardis ER, Ding L et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008 Nov 6; 456 (7218): 6672.
  • 7
    Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004 Oct 22; 306 (5696): 6403.
  • 8
    Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003 Mar 13; 422 (6928): 198207.
  • 9
    Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics 2004 Apr; 3 (4): 36778.
  • 10
    Sreekumar A, Nyati MK, Varambally S et al. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res 2001 Oct 15; 61 (20): 758593.
  • 11
    Kononen J, Bubendorf L, Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998 Jul; 4 (7): 8447.
  • 12
    Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 2001 Apr; 7 (4): 4936.
  • 13
    Shimma S, Sugiura Y, Hayasaka T, Zaima N, Matsumoto M, Setou M. Mass imaging and identification of biomolecules with MALDI-QIT-TOF-based system. Anal Chem 2008 Feb 1; 80 (3): 87885.
  • 14
    Shimma S, Furuta M, Ichimura K, Yoshida Y, Setou M. Direct MS/MS analysis in mammalian tissue sections using MALDI-QIT-TOFMS and chemical inkjet technology. Surf Interface Anal 2006; 38 (2): 171214.
  • 15
    Groseclose MR, Andersson M, Hardesty WM, Caprioli RM. Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry. J Mass Spectrom 2007 Feb; 42 (2): 25462.
  • 16
    Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006 Jan 21; 12 (3): 35462.
  • 17
    Japanese Gastric Cancer A. Japanese classification of gastric carcinoma – 2nd English edn. Gastric Cancer 1998 Dec; 1 (1): 1024.
  • 18
    Schwartz SA, Reyzer ML, Caprioli RM. Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. J Mass Spectrom 2003 Jul; 38 (7): 699708.
  • 19
    Espada A, Rivera-Sagredo A. Ammonium hydrogencarbonate, an excellent buffer for the analysis of basic drugs by liquid chromatography-mass spectrometry at high pH. J Chromatogr A 2003 Feb 14; 987 (1–2): 21120.
  • 20
    Wong JW, Cagney G, Cartwright HM. SpecAlign – processing and alignment of mass spectra datasets. Bioinformatics 2005 May 1; 21 (9): 208890.
  • 21
    Whistler T, Rollin D, Vernon SD. A method for improving SELDI-TOF mass spectrometry data quality. Proteome Sci 2007; 5: 14.
  • 22
    Yanaga Y, Awai K, Nakaura T et al. Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT. AJR Am J Roentgenol 2008 Apr; 190 (4): 10039.
  • 23
    Lemaire R, Desmons A, Tabet JC, Day R, Salzet M, Fournier I. Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections. J Proteome Res 2007 Apr; 6 (4): 1295305.
  • 24
    Seeley EH, Caprioli RM. Molecular imaging of proteins in tissues by mass spectrometry. Proc Natl Acad Sci USA 2008 Nov 25; 105 (47): 1812631.
  • 25
    Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, part I: covalent histone modifications. Trends Mol Med 2007 Sep; 13 (9): 36372.
  • 26
    Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, part II: ATP-dependent chromatin remodeling. Trends Mol Med 2007 Sep; 13 (9): 37380.
  • 27
    Yamamichi N, Inada K, Ichinose M et al. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. Cancer Res 2007 Nov 15; 67 (22): 1072735.
  • 28
    Aoki Y, Toyama A, Shimada T et al. A novel method for analyzing formalin-fixed paraffin embedded (FFPE) tissue sections by mass spectrometry imaging. Proc Jpn Acad Ser B 2007; 83 (2): 20514.
  • 29
    Stauber J, Lemaire R, Franck J et al. MALDI imaging of formalin-fixed paraffin-embedded tissues: application to model animals of Parkinson disease for biomarker hunting. J Proteome Res 2008 Mar; 7 (3): 96978.
  • 30
    Ronci M, Bonanno E, Colantoni A et al. Protein unlocking procedures of formalin-fixed paraffin-embedded tissues: application to MALDI-TOF imaging MS investigations. Proteomics 2008 Sep; 8 (18): 370214.
  • 31
    Sugimura H. Detection of chromosome changes in pathology archives: an application of microwave-assisted fluorescence in situ hybridization to human carcinogenesis studies. Carcinogenesis 2008 Apr; 29 (4): 6817.
  • 32
    Groseclose MR, Massion PP, Chaurand P, Caprioli RM. High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics 2008 Sep; 8 (18): 371524.
  • 33
    Yoshihara T, Kadota Y, Yoshimura Y et al. Proteomic alteration in gastic adenocarcinomas from Japanese patients. Mol Cancer 2006; 5: 75.
  • 34
    Cheng Y, Zhang J, Li Y, Wang Y, Gong J Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. BMC Cancer 2007; 7: 191.
  • 35
    Ohtsu A. Chemotherapy for metastatic gastric cancer: past, present, and future. J Gastroenterol 2008; 43 (4): 25664.
  • 36
    Wang X, Lu Y, Yang J et al. Identification of triosephosphate isomerase as an anti-drug resistance agent in human gastric cancer cells using functional proteomic analysis. J Cancer Res Clin Oncol 2008 Sep; 134 (9): 9951003.